Are you looking for a stock that is relatively undiscovered?
Check out e-MedSoft.com (MDTK).
e-MedSoft.com is leading a transition in the medical industry, as it is the first subscription-based healthcare management system available for delivery through the Internet. The medical software is a complete healthcare management system. Through the Internet, its Java-based integrator, utilizing Sun Microsystem, Inc.'s (NASDAQ:SUNW) Java technology, allows the e-MedSoft.com software to communicate across diverse platforms and languages in unlimited capacity, allowing for the inter link of doctors, hospitals, clinics, HMO's, insurance companies, financiers and government agencies.
For a comparable, look at Healtheon (HLTH), now trading at over 50 times sales and $50 per share. This would suggest MDTK in the $4.00 range is undervalued.
e-MedSoft.com provides an Internet healthcare solution that is fully functional and operational today!
Unlike other Internet sectors (auction sites, selling products, etc.) there are relatively few companies focusing on medical solutions for the Internet, and even fewer that have functional solutions. Nevertheless, healthcare analysts are predicting the use of the Internet for the medical community as inevitable.
Recent Developments:
e-MedSoft.com just completed the acquisition of Relay Business Systems, a United Kingdom based computer software and consulting firm with significant ties to Sun Microsystems. This acquisition establishes for e-MedSoft.com a beachhead in Europe for the launch of its Internet medical software.
e-MedSoft.com just completed an agreement with National Century Financial, one of the largest factors of medical accounts recievables in the country ($6 billion), under which e-MedSoft.com will provide healthcare Internet services to NCFE and the providers it serves.
Visit the Company's web-site at www.mdtk.com.
Please know that this Company is compensating my firm for providing this information (see disclaimer below). Second, please know that because I am in this business, my livelihood would be at risk if I were to make any false or overly-promotional statements. My purpose is to introduce to you a stock that you may not have heard about, and which you may want to consider for your portfolio. I recommend you do your own due diligence, and I would be happy to provide additional information to you, if required.
Michael Manahan
Standard Disclaimer:
This information is supplied by Magnum Financial Group, LLC ("Magnum"). This is not an offer to buy or sell securities. Information or opinions in this report are presented solely for informative purposes, and are not intended nor should be construed as investment advice. Analysis contained herein does not purport to be a complete study of the featured company. Information used and statements of fact have been obtained from the featured company and other sources, but neither guarantee nor representation is made as to completeness or accuracy. Such information is subject to change without notice. Opinions stated may be solely that of Magnum or the indicated sources, and not necessarily those of the featured company. In addition to producing this report, Magnum provides investor relations services for a select number of companies. Magnum currently provides comprehensive investor relations services for e-MedSoft.com and receives compensation in cash (varies from month to month - most recently $10,000) and warrants to purchase 1,050,000 shares of the Company's common stock. Officers, directors, or employees of Magnum, members of their families, and financial analysts mentioned, may hold a position or may from time to time trade in the MDTK stock for their own account. Trademarks are the property of their |
